/Investor DB

Accion — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Banco Contactarbancocontactar.comin𝕏Nov 2024

Banco Contactar is a Colombian financial institution offering microfinance products including microloans, savings accounts, and complementary services to individuals and small businesses.

AgTechFintechImpact & Social GoodBogotá, CO

Co-investorsGlobal Partnerships

First Circlefirstcircle.phin𝕏Oct 2024 · $7M

First Circle is a Philippine fintech building a full-stack neobank for small and medium enterprises, providing financing, cash-flow management tools, and rooftop solar solutions.

Enterprise SoftwareFintechSaaSTaguig, PH

Patrick Lynch(Founder)inJorrit Koop(Founder)inPatrick Lynch Tony Ennis(Founder)Tony Ennis(Founder)

Co-investors500 GlobalInsignia Ventures PartnersMaiora Rebel VenturesSpiral VenturesVenturraAccion Venture Lab+3 more

Flowcartflowcart.aiin𝕏Seed · Jul 2024 · $2M

Flowcart provides AI agents and an in-chat checkout that let e-commerce shoppers browse, add to cart, and pay entirely within WhatsApp, plus tools for cart recovery, winback, upsells, loyalty, and broadcasts.

AI & Machine LearningE-commerceSaaS

Ananth Gudipati(Founder)in

Co-investorsEQ2 VenturesNairobi Business Angel Network

Moffinmoffin.mxinSeed · Jun 2024 · $2M

Moffin is a data integration platform that helps financial institutions, fintech companies, insurers, and other organizations consolidate fragmented data sources to make faster and more confident risk and credit decisions.

Data & InfrastructureEnterprise SoftwareFintechMexico City, MX

Nicholas Yepes(Cofounder & CEO)inSantiago Aceves(Cofounder & CPO)inVictor Diaz(Cofounder & CTO)inVictor Agustin Diaz Mendez(Executive Officer, Director)Jorge Santiago Aceves Cardenas(Executive Officer, Director)

BoardSergio Almaguer(Director)

Co-investorsDigital Currency GroupNew Ventures CapitalAccion Venture LabAngelHub

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.